We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
CJD Support Group Network Australia
www.cjdsupport.org.au
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network
www.docwirenews.com
Eur J Neurol. 2022 May 7. doi: 10.1111/ene.15387. Online ahead of print.ABSTRACTBACKGROUND: Cerebrospinal fluid (CSF) Real Time-Quaking Induced Conversion
Mad cow disease ban for blood donations from UK residents lifted in Australia by TGA
www.abc.net.au
People currently barred from donating blood in Australia will soon be able to roll up their sleeves after the TGA approved Red Cross Lifeblood to receive donations from people who lived in the UK betw...
Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage
www.cureus.com
We herein report a case of genetic Creutzfeldt-Jakob disease (CJD) due to V180I mutation in the prion protein (PrP) gene diagnosed at a preserved cognitive function stage. Although neuropsychological ...
First-ever Creutzfeldt-Jakob disease treatment shows encouraging results
www.healtheuropa.eu
Early study results have highlighted the promising performance of the world’s first treatment for Creutzfeldt-Jakob disease© 2022 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy